Karl Krauth 2880x880px
Back

Karl Krauth

Life is powered by a complex network of proteins interacting with each other. When these interactions go awry, they can cause devastating diseases such as cancer, Alzheimer’s, and arthritis. Yet, despite years of research, predicting the strength of protein-protein interactions remains challenging. As a Branco Weiss Fellow, Dr. Karl Krauth will develop microfluidic instruments capable of measuring millions of protein binding strengths in a single experiment. Using these measurements, he will train machine learning models to accurately predict binding affinities from protein sequences. This research promises to provide new insights into biological functions and aid in the design of life-saving therapeutics.

Background

Nationality
Australia and France

Academic Career

  • PhD in Computer Science at UC Berkeley, United States, 2017–2022
  • BSc (Hons) in Computer Science at the University of New South Wales, Australia, 2012–2016

Major Awards

  • University Medal, University of New South Wales, 2016

Research

Branco Weiss Fellow Since
2024

Research Category
Machine Learning, Microfluidics, Biophysics

Research Location
Department of Genetics, Stanford University, Palo Alto, USA

Background

Although all biological functions depend on protein interactions, we still cannot systematically predict the binding affinity of two protein sequences. Protein-protein interactions (PPIs), especially those related to cell signaling, are often weak and transient, making them difficult to measure. While advances in machine learning have revolutionized protein folding, applying these models to predict protein binding has produced inconsistent results since the training data and models are not tailored for PPIs. Therefore, developing machine learning algorithms that accurately predict PPIs will require new model architectures and, crucially, a new kind of data.

Details of Research

Dr. Karl Krauth’s background as a machine learning researcher embedded in a microfluidics laboratory uniquely positions him to tackle the protein interaction problem. In his project, Dr. Krauth will develop a platform that integrates valved microfluidic technology, cDNA display, and next-generation sequencing to quantify the binding strength of over ten million distinct PPIs in a single experiment. This technology will enable him to collect the largest and most detailed PPI dataset to date, reporting thermodynamic and kinetic quantities across protein families spanning the proteome. He will use this dataset to train a deep learning model capable of predicting PPIs directly from sequences. By incorporating an active learning algorithm, he will iteratively refine the model through subsequent rounds of machine-learning-guided data collection.